OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Marc Weksler

1 Projects | 1 Researchers | $80,210 Invested

2002

Weill Medical College of Cornell University

Marc Weksler, PhD

Human anti-A Beta Antibodies for the Treatment of Alzheimer's Disease

  • Funding Amount: $80,210
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed